Latest Expert Exchange Queries
sitemapHome | Registration | Job Portal for CA's | Expert Exchange | Currency Converter | Post Matrimonial Ads | Post Property Ads
News shortcuts: From the Courts | News Headlines | VAT (Value Added Tax) | Service Tax | Sales Tax | Placements & Empanelment | Various Acts & Rules | Latest Circulars | New Forms | Forex | Auditing | Direct Tax | Customs and Excise | ICAI | Corporate Law | Markets | Students | General | Indirect Tax | Mergers and Acquisitions | Continuing Prof. Edu. | Budget Extravaganza | Transfer Pricing
Popular Search: TDS :: articles on VAT and GST in India :: due date for vat payment :: ICAI offer Get Windows 7,Office 2010 in Rs.799 Taxes :: VAT Audit :: form 3cd :: ACCOUNTING STANDARDS :: Central Excise rule to resale the machines to a new company :: ACCOUNTING STANDARD :: ARTICLES ON INPUT TAX CREDIT IN VAT :: cpt :: list of goods taxed at 4% :: empanelment :: TAX RATES - GOODS TAXABLE @ 4% :: VAT RATES
« News Headlines »
 India is moving towards a flawed GST
 ICAI to organise two-day international conference in Hyderabad
 Here's how to calculate tax payable on your capital gains
 Income Tax calculations for the financial year 2016-17
 CPE Events 17 October - 22 October 2016
 High Court raps I-T Department for wrong tax demand
  CBDT signs 5 advance pricing pacts with Indian taxpayers
 Finance ministry warns tax officials of action against GST protest
 Big changes for small units under GST
 Parliament’s winter session to begin on November 16 to expedite GST rollout
 Income-tax (27th Amendment) Rules, 2016 - 92/2016

`Extend R&D tax benefits to pharma cos'
December, 21st 2006

The Associated Chambers of Commerce and Industry of India (Assocham) has called on the Government to extend the tax benefits available for R&D to pharmaceutical companies by 10 years. The provisions of Section 35 (2AB) of the I-T Act are to expire on March 31, 2007.

Assocham says that without tax exemption, the domestic pharmaceutical industry would have to incur huge expenditure, and that an extension till 2017 would help the industry in long-term planning and research to face competition.

The chamber has written to the Ministries of Chemicals and Fertilisers and Finance for the same, pointing out that while the R&D spend by major Indian companies is only about 5 per cent of their turnover, globally large pharma companies spend 15 per cent on R&D.

R&D spend

According to Assocham, R&D spend has grown at CAGR of 38 per cent between 2001-2006. Additionally, the chamber has also asked for exemption for services provided and availed in R&D, import of capital goods for R&D and expenditure on clinical trials, under the above Act.

It has also urged the Government to exempt import duty on clinical trial samples and authorise the Drug Controller General of India to decide who qualifies. The industry body would also like clinical trials conducted by Indian companies outside the country to enjoy the same tax benefits that they do when they conduct them within the country.

Home | About Us | Terms and Conditions | Contact Us
Copyright 2016 CAinINDIA All Right Reserved.
Designed and Developed by Binarysoft Technologies Pvt. Ltd.
SEO Company Search Engine Optimization Company US SEO Local SEO Company Website SEO Company Alabama SEO Company Alaska SEO Company Arizona SEO Company Arkansas SEO Company California SEO Company Colorado SEO Company Connecticut SEO Company Delawa

Transfer Pricing | International Taxation | Business Consulting | Corporate Compliance and Consulting | Assurance and Risk Advisory | Indirect Taxes | Direct Taxes | Transaction Advisory | Regular Compliance and Reporting | Tax Assessments | International Taxation Advisory | Capital Structuring | Withholding tax advisory | Expatriate Tax Reporting | Litigation | Badges | Club Badges | Seals | Military Insignias | Emblems | Family Crest | Software Development India | Software Development Company | SEO Company | Web Application Development | MLM Software | MLM Solutions